Dhaka | Sunday | 20th of June 2021 | Bangla Version | Get Our App EN
  • TECH
  • ♦ MORE ♦
  • ♦ MORE LINK ♦
    • NBS » 1-Headlines » Breaking: Iran launches 3rd stage in human trial of COVIran vaccine

    Please subscribe to NBS YouTube channel:

    Breaking: Iran launches 3rd stage in human trial of COVIran vaccine
    NBS | Sunday, April 25th, 2021 | Published: 6:31 pm

    Breaking: Iran launches 3rd stage in human trial of COVIran vaccine

    Iran has launched the third stage in the clinical trial of a vaccine produced by experts at the Headquarters for Executing the Order of Imam Khomeini (EOIK) against the COVID-19 disease.

    According to Press TV, COVIran Barekat named after the pharmaceutical group that developed it was administered to three volunteers at a ceremony in Tehran’s Eram Hotel on Sunday.

    Among the volunteers was Dr. Minoo Mohraz, a member of national coronavirus taskforce and an infectious diseases specialist.

    The third stage of the vaccine’s human trial involves 20,000 people in the cities of Tehran, Bushehr, Shiraz, Karaj, Mashhad and Isfahan.

    In a post on his Twitter account, head of the EOIK public relations, Hojjat Niki Maleki, said more than 32,000 people have expressed willingness to participate in the vaccine’s clinical trial.

    The COVIran vaccine went into human trial on December 29, 2020, after successfully completing the initial steps, including tests on animals, and obtaining necessary approvals.

    The second homegrown vaccine is a product of the Razi Vaccine and Serum Research Institute. Razi COV-Pars — an mRNA recombinant vaccine — is administered via injection and inhalation.

    The third vaccine, named Fakhra, is developed by the Iranian Defense Ministry’s research center formerly headed by nuclear scientist Mohsen Fakhrizadeh, who was assassinated in a suspected Israeli-linked terror attack late last year.

    In addition to producing domestic vaccines, Iran has imported reliable foreign vaccines from Russia, China, India and Cuba amid the illegal US sanctions that have seriously hampered the country’s fight against the coronavirus pandemic.

    Earlier this month, Iran received over 700,000 doses of the Oxford-AstraZeneca vaccine as part of its purchase of millions of doses through the COVAX initiative.


    Read on the original site

    Write your comment...

    nbs24new3 © All Rights Reserved
    News Broadcasting Service - NBS
    (NBS) 2015 - 2020

    CEO: Abdullah Al Masum,
    Editor and Publisher : Sultana Rabiya
    Bangshal, Dhaka-1000, Bangladesh.
    Cell : +88 02 , +88 01718 580 689
    Email : news@nbs24.org, thenews.nbs@gmail.com

    USA Office: 41-11, 28th Avenue, Suite # 15 (3rd floor), Astoria, New York-11103,
    United States of America. Cell: 917-396-5705.

    Prasenjit Das, Editor in Chief, India.
    Address : Central Road, Town Pratapgarh, Agartala, Tripura, India. +919402109140.

    Home l About NBS l Contact the NBS l DMCA l Terms of use l Advertising Rate l Sitemap l Live TV l All Paper

    Reproduction of content, news or article published on this nbs website is strictly prohibited. - Privacy Policy